2025 annual financial data
ALX Oncology Holdings 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -104,021,000 USD and net income was -101,695,000 USD.
Operating cash flow was -84,142,000 USD.
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -104,021,000 USD
- Net income
- -101,695,000 USD
- Operating cash flow
- -84,142,000 USD